Psychopharmacology and Psychiatry Updates cover image

Choosing First-Line Antipsychotics: Considering Violence

Psychopharmacology and Psychiatry Updates

00:00

Rationale for Including Olanzapine Despite Metabolic Risks

Dr. Freudenreich defends olanzapine use based on effectiveness, adherence, and data showing no worse long-term mortality compared to others.

Play episode from 06:16
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app